http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CU-20160063-A7

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cf32b60391b469c41e86c353437f5751
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4745
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4439
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D231-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4162
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-416
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D491-052
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4162
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04
filingDate 2014-11-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_db8bb1281fcbbf54a25efde22acef76d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_afef67a927e677070972aaf73e0afc82
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aba79aac580b6e56e94d7ab49ba373b9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cf1d510a675a299ac420f12d76d80597
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_061f5c239ce658b194c041aa5d8efb38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2c42301aa35cee166fade2ed456ee39d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e172f775bf7c1a54ba407a695ece9ed3
publicationDate 2016-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CU-20160063-A7
titleOfInvention ACTIVE FUSIONED PIRAZOL DERIVATIVES AS FARNESOID X RECEPTOR MODULATORS
abstract The present invention relates to fused pyrazole derived compounds of formula I: SPACE FOR FORMULA a stereoisomer, enantiomer, a pharmaceutically acceptable salt or an amino acid conjugate thereof; where the variables are as defined in this document; and its pharmaceutical compositions, which are useful as modulators of the activity of X-farnesoid receptors (FXR).
priorityDate 2013-11-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID452162
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID612928
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1048
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID20186
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425914843
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID60351
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID540528
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID373902
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID9971
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID436847

Total number of triples: 44.